# Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients

> **NCT03090893** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Antithrombin Deficiency Type 2

## Interventions

- **DRUG:** ATryn continuous infusion

## Key facts

- **NCT ID:** NCT03090893
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI passed away
- **Last updated:** 2018-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03090893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03090893, "Response of Continuous Recombinant Antithrombin Infusion in Postcardiotomy ECMO Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03090893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*